Top Law Firms in Euless, TX 76039

The Law Offices of Jeff C. Kennedy combines compassion and personal attention with in-depth criminal defense knowledge and practical experience. If you're in trouble with the law, we're here to hel...Read More…

Recent Reviews View all

GETLEGAL.com

4.0

By Papierre.com

Hello The AttorneyStore.Com, Thanks for accepting my invitation, as I am be honored to have you as my Friend. If you have a chance today, look inside my store and tell me What you like about it? Check it out. http://www.papierre.com Your endorsement means a lot to me. Thanks! Best Regards, Patrick ...read more

GETLEGAL.com

These people really know their stuff!!!! ...read more

GETLEGAL.com

5.0

By Steven Proboda

Could find attorney and information. Easy to find infomation ...read more

Blogs View more

5 Reasons to Measure User Response to Video on Law Firm Websites

by Akhil Saklani, chief operating officer of GetLegal.comYou have filmed videos for your law firm and uploaded them to your website. The next step is to measure how users respond to your videos. The ability to measure video performance online is a relatively new practice that gives your firm knowledge about how visitors interact with your site. You can measure how visitors find your videos, how long they watch and how many they watch. Here are five advantages to measuring video performance.1. Know how many visitors watch videos.Perhaps the most important statistic in the measurement of video performance is knowing how many potential clients are actually watching your videos. If most visitors don't watch your videos, your firm may need a new strategy to increase viewership. Making video play automatically on a page may encourage users to watch your other videos.2. Track the viewing time of your visitors.How many potential clients watch your videos all the way through? Knowing the amount of time users spend viewing your videos is useful information. A video that the majority of viewers stop watching after 10 seconds could signal a problem with the video's quality or content. The goal is to create videos that are long enough to get your point across but not too long that viewers lose interest.3. Monitor visitor activity during viewing.Don't expect visitors to watch your videos to the end without interruption. Just as people pause or fast-forward through movies at home, they do the same with videos online. Software that analyzes video performance gives you the power to see how visitors interact with your videos. Do most visitors skip certain parts of a video? How often do they pause or stop the video? These statistics can tell you if your video is too long or not interesting enough.4. Learn the number of videos each visitor views.Let's say you have multiple videos on your website. How many potential clients watch more than one video? If most watch only one, the rest of your videos are not being used to their potential. Perhaps your videos are not easily accessible or your main video does not impress viewers. It's important that the first video potential clients see gives them a reason to watch your other videos. The more videos they watch, the more likely they'll consider your firm for representation.5. Understand how visitors find your videos.Potential clients can find your videos in multiple ways. The most common way is for them to stumble upon the videos while browsing your website. But now, videos are beginning to show up on search engines. For instance, if you have a video that gives an overview of consumer law, a potential client searching for "consumer law" might find your video on Google. Video-performance software will show you what sources refer users to your videos the most. If you notice that few visitors find your videos with search engines, consider implementing a search engine marketing campaign to increase your video presence on search engines. ...read more

By GETLEGAL.com March 13, 2011

FDA Bureaucratic Activism Protects Big Pharmaceutical Companies

By Robert A. Schwartz, Attorney at Law, Contributing Columnist On January 16, 2008, the FDA issued a proposed rule which directly contradicts Congress’ expressed intent when it passed the Food and Drug Administration Amendments Act of 2007 (FDAAA). Unlike the FDA’s proposed rule, Congress’ intended duty to warn consumers of a drug’s hazards rests with the drug company, who is in the best position to warn about problems associated with the drug. However, under the FDA rule, drug companies will enjoy more relaxed labeling requirements and will use the rule to claim immunity for failing to warn patients of potential drug hazards. The Food and Drug Administration Amendments Act, passed just four months ago, requires a drug company to update its label to include drug hazard warnings as soon as there is reasonable evidence of that risk. This law allows consumers to be aware of a drug’s potential risks at the earliest possible moment and prevents injuries and deaths such as those associated withAvandiaand Vioxx. However, under the new FDA rule, drug companies will only have to revise their warning label where they establish ''sufficient evidence of a causal association,'' which could take years. This is a significantly higher standard that drug companies would have to meet before informing consumers of a potential hazard. Congress must hold oversight hearings to curb this agency’s abuse of power for the following reasons: The FDA has ignored expressed congressional intent. Although Congress clearly intended NOT to loosen the requirements on drug companies to inform consumers of potential drug hazards, the new FDA rule will give drug companies broad discretion to determine whether to warn consumers. The proposed rule is a step backwards from making drugs safer. The new FDA rule will take power away from the FDA to require drug companies to warn consumers of potential problems withprescription drugsat the earliest possible time. It will give drug companies the ability to choose not to inform consumers even if there is new evidence of a potential hazard. The proposed rule will make it more difficult for consumers injured by prescription drugs to hold negligent drug companies accountable. Under the FDA’s new rule, the manufacturer will be immunized from accountability by claiming that it did not have sufficient evidence to require it to update its label. Without the ability to hold the manufacturer accountable under the FDAAA for failure to warn, the consumer loses this recourse for its injuries and could become a burden to taxpayers. The FDA is contributing to a pattern of Bush Administration agencies ignoring clear congressional intent. For example, after Congress passed Public Law 110-53, which preserved railroad derailment victims’ rights, the Federal Railroad Administration issued a proposed rule which sought to provide immunity to negligent railroad companies in the event of a commuter train derailment. Congress must act to investigate the FDA’s attempt to usurp the authority of Congress to protect the health and safety of their constituents. By using their oversight authority, Congress must ensure that unelected bureaucrats are not ignoring explicit Congressional intent. We must end this Bureaucratic Activism. Legal Help Center|Find an Attorney ...read more

By GETLEGAL.com February 10, 2008

Related Articles View more

How to File a Medical Malpractice Suit

A medical malpractice suit can be filed anytime a person feels they have been injured or harmed during the course of a medical procedure. It c... read more

How to Do an Uncontested Divorce on Your Own

Getting a divorce is never a pleasant experience. The cost of attorneys and court fees adds to the stress of the divorce. If both parties are in agreement with no party contesting any part of the divorce, you can file for a DYI uncontested divorce. ...read more

About International Divorce Law

International divorce law can be complicated because national divorce laws vary from one another. If the couple is from different countries, one country's divorce laws may have jurisdiction over the couple in regards to the division of property and custody of children. ...read more